The choppy nature of the 1st quarter is not surprising after the action in 2013. The sharp declines in the Nasdaq 100 and biotechnology stocks have caused some technical damage that would normally take time to repair.
The relative performance analysis of the SPDR Diamond Trust (DIA) suggests that it may be taking over market leadership. It has lagged for the past year as it is up just 13.8% versus a 21.1% gain in the Spyder Trust (SPY) and 26% gain over the past year in the PowerShares QQQ Trust (QQQ).
The longer-term analysis of the on-balance volume (OBV) often gives one a very good idea of which stocks are being accumulated. This is especially true of the monthly and quarterly OBV analysis. These four Dow stocks are giving some strong long-term signals that indicate one should be looking to buy them at a price level where the risk can be well controlled.
Click to Enlarge
Top US Companies To Invest In 2015: Sa Sa International Holdings Ltd (SAXJF)
Sa Sa International Holdings Limited is an investment holding company. The Company�� subsidiaries are principally engaged in the retailing and wholesaling of cosmetic products. Its business covers Hong Kong and Macau, Mainland China, Taiwan, Singapore, and Malaysia. The Company operates in two segments: retail segment, engaged in the operation of cosmetics specialty stores, which offer a variety of products from over 600 beauty brands, covering a wide of products from skin care, fragrance, make-up, body care and hair care to health foods, and brand management segment, engaged in the management of over 100 beauty brands. It also offers round-the-clock online shopping services along with product and corporate information through its e-commerce platform, sasa.com. The Company�� subsidiaries include Alibaster Management Limited, Base Sun Investment Limited, Cyber Colors Limited, Docile Company Limited and Elegance Trading (Shanghai) Company Limited, among others. Advisors' Opinion:- [By WWW.MARKETWATCH.COM]
HONG KONG (MarketWatch) -- Hong Kong stocks swung between small gains and losses early Thursday after hitting a seven-month high in the previous session, with the Hang Seng Index (HK:HSI) down less than 0.1%. Most mainland Chinese property developers outperformed the markets, with Guangzhou R&F Properties Co. (HK:2777) (GZUHF) rallying 3.4%, after the company reported a 44% month-on-month jump in sales for June. Shimao Property Holdings Ltd. (HK:0813) (SIOPF) climbed 2.6%, and China Resources Land Ltd. (HK:1109) (CRBJF) rose 1.7%. However, several retailers were weak, as Want Want China Holdings Ltd. (HK:0151) (WWNTF) , the country's top food and beverage maker, declined 2%. Hong Kong-based cosmetics brand Sa Sa International Holdings (HK:0178) (SAXJF) fell 1.6%, with a decline in Chinese June non-manufacturing data helping weigh on some retailers. Over on the Chinese mainland, the Shanghai Composite Index (CN:SHCOMP) retreated 0.4%, pulling back from its highest close in two weeks.
Top Rising Stocks To Invest In 2014: Flushing Financial Corporation (FFIC)
Flushing Financial Corporation operates as the holding company of Flushing Savings Bank, FSB that provides banking products and services primarily to consumers and businesses. The company?s deposit products include savings accounts, money market accounts, demand accounts, negotiable order of withdrawal accounts, and certificates of deposit. Its loan products portfolio comprises one-to-four family, multi-family residential, and commercial real estate mortgage loans; construction loans, primarily for residential properties; small business administration loans and other small business loans; mortgage loan surrogates, such as mortgage-backed securities; U.S. government securities, corporate fixed-income securities, and other marketable securities; and consumer loans, including overdraft lines of credit. The company also offers Internet banking services through iGObanking.com. As of December 31, 2010, it conducted its business through 16 full-service offices located in the New York City Boroughs of Queens, Brooklyn, and Manhattan, as well as in Nassau County, New York. The company was founded in 1929 and is based in Lake Success, New York.
Advisors' Opinion:- [By Marc Bastow]
Savings and loan holding company Flushing Financial (FFIC) raised its quarterly dividend 15% to 15 cents per share, payable March 28 to shareholders of record as of March 7.
FFIC Dividend Yield: 2.86% - [By Tim Melvin]
I always find it very interesting to see what long-term investors are selling in a given quarter. Kahn Brothers lightened up on many financials that have shot up and now trade above book value. The firm sold out of Flushing Financial (FFIC), TCF Financial (TCB) and Dime Community Bank (DCOM). Khan apparently shares my views on the large-cap drug stocks, easing up on both Pfizer (PFE) and Bristol Meyers (BMY) over the summer. Khan Brothers also sold the last of the Travelers shares (TRV) it has owned since 2008 at more than twice the purchase price.
Top Rising Stocks To Invest In 2014: U.S. Global Investors Inc.(GROW)
U.S. Global Investors, Inc. is a publicly owned investment manager. The firm primarily provides its services to investment companies. It also provides its services to pooled investment vehicles. The firm manages mutual funds for its clients. It invests in the public equity and fixed income markets across the globe. The firm invests in value stocks to make its equity investments. It employs a fundamental and technical analysis with bottom-up and top-down analysis to make its investments. The firm typically invests in companies specializing in gold and natural resources. U.S. Global Investors, Inc. was founded in 1968 and is based in San Antonio, Texas.
Advisors' Opinion:- [By Morgan Myrmo]
One business that is ripe for takeover is U.S. Global Investors (GROW), a micro-cap asset manager based in San Antonio, Texas. The company specializes in the management of gold, mineral, resource and high-growth emerging market mutual funds. U.S. Global fund values have been hammered over the last five years as the current economic recovery has yet to reach commodities and emerging markets.
Top Rising Stocks To Invest In 2014: Cubist Pharmaceuticals Inc.(CBST)
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), a once-daily, bactericidal, intravenous, antibiotic with activity against gram-positive organisms, including methicillin-resistant staphylococcus aureus. Its clinical development product pipeline consists of CXA-201, which is in the phase III clinical trial for patients with complicated urinary tract infections; and in phase II clinical trial for patients with complicated abdominal infections. The company is also developing CXA-201 for the treatment of hospital acquired pneumonia. In addition, its product under development comprises CB-183,315, an oral, bactericidal lipopeptide with in vitro bactericidal activity against C. difficile, for the treatment of clostridium difficile-associated diarrhea (CDAD). Further , the company?s pre-clinical programs include therapies to treat various bacterial infections and agents to treat acute pain. Additionally, it promotes MERREM I.V. (meropenem for injection), a carbapenem class intravenous antibiotic, in the United States under a commercial services agreement with AstraZeneca Pharmaceuticals, LP; and DIFICID as the treatment for CDAD in adults under the co-promotion agreement with Optimer Pharmaceuticals, Inc. The company also has collaborations with Forma Therapeutics, Inc. to discover and develop antibacterial compounds; an agreement with the Broad Institute to transform natural products discovery; a collaboration with Hydra Biosciences, Inc., to develop ion channel drugs; and a collaboration agreement with Alnylam Pharmaceuticals, Inc., for the development and commercialization of Alnylam's RNAi therapeutics as a therapy for the treatment of respiratory syncytial virus. The company was founded in 1992 and is headquartered in Lexington, Mas sachusetts.
Advisors' Opinion:- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
Cubist Pharmaceuticals Inc.(CBST) said the Food and Drug Administration accepted for priority review the company’s new drug application for its investigational antibiotic for complicated urinary tract and complicated intra-abdominal infections. Shares rose 3.6% to $71 premarket.
- [By Lee Jackson]
Cubist Pharmaceuticals Inc. (NASDAQ: CBST) is another top stock to buy making acquisitions. It recently received antitrust clearance for its�purchase of Trius Pharmaceutical. The acquisition strengthens its already strong antibiotic franchise. UBS has a $70 price target, and the consensus is placed at $65.
- [By Jake Keator]
Shares of Cubist Pharmaceuticals (NASDAQ: CBST ) exploded upward on Friday, finishing up over 9%. The company reported strong second-quarter results Thursday, beating average analyst estimates for both revenue and EPS. Total net revenues were $258.8 million, up 12.2% over Q2 2012, while non-GAAP diluted EPS was $0.42. Average analyst estimates were $254.73 million for revenue and EPS of $0.38.
- [By Rich Bieglmeier]
[Related -Cubist Pharmaceuticals Inc. (CBST): All-Time Highs On The Horizon?]
The FDA has accepted the Company's New Drug Application (NDA) for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of June 20, 2014. Cubist is seeking FDA approval of tedizolid for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Top Rising Stocks To Invest In 2014: Lufkin Industries Inc.(LUFK)
Lufkin Industries, Inc. manufactures and supplies oilfield and power transmission products for use in energy infrastructure and industrial applications. The company operates through two segments, Oil Field and Power Transmission. The Oil Field segment manufactures and services artificial lift products, including reciprocating rod lift equipment, including air-balanced, beam-balance, crank-balanced, Mark II Unitorque, and hydraulic units. It also transports and repairs pumping units; and refurbishes used pumping units. In addition, this segment designs, manufactures, installs, and services computer control equipment and analytical services for artificial lift equipment, as well as operates an iron foundry to produce castings for new pumping units. Further, the Oil Field segment provides gas lift, plunger lift, and completion equipment. The Power Transmission segment designs, manufactures, and services speed increasing and reducing gearboxes. It also manufactures capital spa res for customers in conjunction with the production of new gearboxes, as well as produces parts for after-market service. In addition, this segment provides on and off-site repair and service for its own products, and also those manufactured by other companies. Further, the Power Transmission segment is involved in analysis, design, and manufacture of precision, custom-engineered tilting-pad bearings and related components for high-speed turbo equipment operating in critical duty applications, as well as services, repairs, and upgrades turbo-expander process units for air and gas separation. The company markets its products and services primarily in the United States, Europe, Canada, Latin America, the Middle East, and north Africa. Lufkin Industries, Inc. was founded in 1902 and is based in Lufkin, Texas.
Advisors' Opinion:- [By reports.droy]
While GE has seen some organic growth in this line of business, acquisitions have been its key driver. Between 2010 and 2013, GE has spent over $11 billion on acquisitions linked to this industrial segment. The most notable of these was the deal to acquire Lufkin (LUFK) in 2013, for which the company paid a premium of 40%. By acquiring Lufkin, GE was able to acquire a specialized equipment provider for oil and gas wells, specifically those involved with artificial lift technology.
Top Rising Stocks To Invest In 2014: Neogen Corporation(NEOG)
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. The company?s Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, drug residues, pesticide residues, and general sanitation concerns. Its products also comprise bioluminescence-based diagnostic technology for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, food and beverage processors, and dairies; laboratories and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various re gulatory agencies. The company?s Animal safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals and diagnostic products, and genetic testing services to the animal safety market. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. This segment?s products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, it offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in La nsing, Michigan.
Advisors' Opinion:- [By MONEYMORNING.COM]
And with very quick gains of 9% in BRF SA (NYSE ADR: BRFS), 5.2% in South American agricultural play Adecoagro SA (NYSE: AGRO) and 1.6% in high-tech agribusiness player Neogen Corp. (Nasdaq: NEOG), we're doing well with our plays on (pockets of) accelerating U.S. inflation.
No comments:
Post a Comment